Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

  • Stage: Pre-B轮, 2500万美元。
  • Honors: 高新技术企业 科技型中小企业 According to algorithm
  • Salary: 100% of positions earn 8-50K,。Master's salary: ¥40.0K, Doctorate salary: ¥40.0K.
  • Recruiting: In 2026 vs 2025grew by 300%.
  • Requirement: Education: 硕士 leads with 45.2%. Experience: 3-5年 leads with 35.5%.
  • Region: Distributed across 1 regions, 上海: 100%.

About the Company

大睿生物Rona Therapeutics为致力于研发革新性核酸类药物的人才提供大展宏图的机会和平台,我们投身于不同的治疗领域,全力以赴优化疾病的治疗路径和治疗手段。这段旅程需要一个充满激情、有坚定信念以及极富创造力的团队来实现科学上的卓越攀登。大睿生物有志于进行真正的创新药物研发,帮助患者更健康、更长寿,同时创造这样的环境:赋能他人,共同成就!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

大睿生物 Financing History (4 rounds)

Manage
Pre-B轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 2500万美元
  • Investor: 光华开源,礼来亚洲基金,博...

大睿生物 How Fast Is Hiring Growing?

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 53%
  • 2024: Down 6%
  • 2023: Up 45%
大睿生物 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at 大睿生物医药科技(上海)有限公司 growing? 大睿生物2025: 7 openings (down 53%), 2024: 15 openings (down 6%), 2023: 16 openings (up 45%), 2022: 11 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

大睿生物 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 40%
  • 2024: Down 29%
  • 2023: Up 17%
大睿生物 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 大睿生物医药科技(上海)有限公司 growing? 大睿生物Master's recruitment over the years: 2025: 3 openings (down 40%), 2024: 5 openings (down 29%), 2023: 7 openings (up 17%), 2022: 6 openings.

大睿生物 Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
大睿生物 Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 大睿生物医药科技(上海)有限公司 growing? 大睿生物Doctorate recruitment over the years: 2026: 3 openings (up 267%), 2024: 5 openings (down 29%), 2023: 4 openings (up 17%), 2022: 5 openings.

大睿生物 — What Are the Salaries Like? (12 records)

Manage
大睿生物 Salary Overview
salary range: 8K - 50K, 100% of roles pay ¥8-50K
Note: salary statistics are based on 12 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 大睿生物医药科技(上海)有限公司?大睿生物100% of positions earn 8-50K, Undergraduate salary: ¥。医疗卫生/美容保健类 average salary ¥26.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

大睿生物 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

大睿生物 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 医疗卫生/美容保健类
    41.9% of total 41.9%
  • 经营管理类
    29% of total 29%
  • 质量管理类
    22.6% of total 22.6%
  • 其他(研发和技术类)
    19.4% of total 19.4%

Education

  • 硕士
    45.2% of total 45.2%
  • 大专
    22.6% of total 22.6%
  • 本科
    22.6% of total 22.6%
  • 博士
    9.7% of total 9.7%

Experience

  • 3-5年
    35.5% of total 35.5%
  • 5-10年
    32.3% of total 32.3%
  • 1-3年
    22.6% of total 22.6%
  • 不限
    9.7% of total 9.7%
View Detailed Analysis

What does 大睿生物医药科技(上海)有限公司 require? Who is 大睿生物 hiring? 大睿生物 recruitment: 医疗卫生/美容保健类占比最多占41.9%,其次是经营管理类占29%. What education can get in at 大睿生物? 硕士占比最多占45.2%,其次是大专占22.6%. High education required at 大睿生物? 硕士占45.2%,博士占9.7%. Work experience required at 大睿生物? 3-5年占比最多占35.5%,其次是5-10年占32.3%. Where are the job locations at 大睿生物? 上海占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 2,500万(美元)
Legal Representative: 史艺宾
Date Established:
Credit Code: 91310115MA1K4UL55B
Registered Address: 上海市浦东新区康威路795弄3号楼

Talent Demand Trend Analysis More

Partners & Suppliers

大睿生物授权金赛药业在大中华区开发特定靶点的RNAi药物,金赛药业支付首付款和里程碑付款。 Source
合作客户 技术授权/合作开发
康龙化成为大睿生物提供小核酸药物的临床前研发服务,包括药物发现、药效评估等。 Source
供应商 CRO服务

People who follow 大睿生物 also follow

大睿生物 Competitors (Similar Companies)

“药物体外筛选技术和早期药物机理研究”
房地产开发 洋房 城市建设 城乡建设
偶联药物 药物研发 单克隆抗体药物 医药
医药 生物制品 生物医药
制药/药业 医药 医药中间体 中间体
消防车 消防救援 飞行平台 飞行汽车
“Research, development, and production of anti-tumor and surgical medic”
“Top 100 Chinese Pharmaceutical Enterprises”

Discover Great Companies, Discover Great Clients

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates